SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-19-000026
Filing Date
2019-11-12
Accepted
2019-11-12 16:30:55
Documents
74
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q egrxq32019.htm   iXBRL 10-Q 1468345
2 EXHIBIT 10.1 exhibit101revcreditk.htm EX-10.1 1043962
3 EXHIBIT 31.1 exhibit311q32019.htm EX-31.1 9701
4 EXHIBIT 31.2 exhibit312q32019.htm EX-31.2 9664
5 EXHIBIT 32.1 exhibit321q32019.htm EX-32.1 10020
11 asfiledeaglepharma201_image1.gif GRAPHIC 2551
  Complete submission text file 0000827871-19-000026.txt   8373195

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20190930.xsd EX-101.SCH 41688
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20190930_cal.xml EX-101.CAL 104176
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20190930_def.xml EX-101.DEF 233739
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20190930_lab.xml EX-101.LAB 629859
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20190930_pre.xml EX-101.PRE 392134
25 EXTRACTED XBRL INSTANCE DOCUMENT egrxq32019_htm.xml XML 1217162
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 191209999
SIC: 2834 Pharmaceutical Preparations